3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
13
Thoracic
4
Gastrointestinal
4
Plasma cell
3
Lymphoid
3
Head & Neck
3
Tumor-Agnostic
1
Sarcoma
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Gynecologic
1
Genitourinary
1
CNS
1
Conditions
Uterine Cervical Neoplasms
1
Sarcoma
1
Pancreatic Neoplasms
1
Motor Activity
1
Head and Neck Neoplasms
1
Fatigue
1
Esophageal Neoplasms
1
Carcinoma, Bronchogenic
1
Brain Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
13
Ifosfamide
12
Doxorubicin
12
Blood Specimen Collection
12
Radiotherapy
11
Methotrexate
10
fludarabine phosphate
9
Surgical Procedures, Operative
9
Radiosurgery
9
Cyclophosphamide
9
Surveys and Questionnaires
8
Cyclosporine
8
Proton Therapy
7
Peripheral Blood Stem Cell Transplantation
7
Busulfan
7
Mycophenolic Acid
6
Melphalan
6
Whole-Body Irradiation
5
Standard of Care
5
Filgrastim
5
Etoposide
5
Early Intervention, Educational
5
Carboplatin
5
Biopsy
5
Antilymphocyte Serum
5
Vincristine
4
Temozolomide
4
Sunitinib
4
Radiation Dose Hypofractionation
4
Mesna
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Exercise Therapy
×
Sarcoma
×
Clear all
NCT04517019
2020-08-18
OnkoFit II
University Hospital Tuebingen
Phase NA
Unknown
201 enrolled